STOCK TITAN

If You Invested in Blade Air Mobility, Inc. (BLDE)

Industrials · Airports & Air Services · NASDAQ
See the BLDE overview
BLDE has not traded since Aug 28, 2025. Its last close was $4.73, so every figure on this page ends there and the 1, 5 and 10 year results count back from that close.
$1,000 invested 1 Year Before Its Last Close
$1,546
+54.6% price return 54.6% CAGR
+54.6% with dividends reinvested
Bought on Aug 28, 2024 at $3.06 split-adjusted
$1,000 invested 5 Years Before Its Last Close
$473
-52.7% price return -13.9% CAGR
-52.7% with dividends reinvested
Bought on Aug 28, 2020 at $9.99 split-adjusted
$1,000 invested 10 Years Before Its Last Close
N/A
Our prices start Nov 6, 2019

What $1,000 or $10,000 in BLDE Was Worth at Its Last Close

Real historical value by amount invested and how long before the last close
If you invested 1 year before 5 years before 10 years before Since Nov 6, 2019
$1,000 $1,546 +55% $473 -53% — $485 -51%
$10,000 $15,458 +55% $4,735 -53% — $4,851 -51%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2025-08-28. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for BLDE

$1,000 Investment Over Time

BLDE vs S&P 500

Year-by-Year Returns

BLDE annual performance
Year Start Price End Price Annual Return Cumulative
2019Nov 6 to Dec 31 $9.75 $9.83 +0.8% +0.8%
2020 $9.83 $11.08 +12.7% +13.6%
2021 $11.08 $8.83 -20.3% -9.4%
2022 $8.83 $3.58 -59.5% -63.3%
2023 $3.58 $3.53 -1.4% -63.8%
2024 $3.53 $4.25 +20.4% -56.4%
2025Dec 31, 2024 to Aug 28 $4.25 $4.73 +11.3% -51.5%

About Blade Air Mobility, Inc.

Industrials · NASDAQ

Blade Air Mobility, Inc. (NASDAQ: BLDE), which has changed its corporate name to Strata Critical Medical, Inc. as disclosed in SEC filings, has historically operated as a technology-powered air mobility platform. Under the BLDE ticker, the company combined aviation logistics with software and terminal infrastructure to provide air transportation and logistics services for both medical and passenger use.

According to multiple company press releases, Blade Air Mobility has provided air transportation and logistics for hospitals across the United States, where it is described as one of the largest transporters of human organs for transplant. In addition, it has provided passenger services using helicopter and fixed-wing aircraft, with routes and services focused primarily on the Northeast United States, Southern Europe and, at times, Western Canada. The company has been based in New York City and has emphasized an asset-light model, relying on third-party aircraft operators while focusing on logistics, technology, and customer interface.

Blade’s business model, as described in its news releases, has centered on coordinating and arranging flights operated by other entities, managing passenger terminal and lounge infrastructure in key urban markets, and providing time-sensitive medical logistics. Its proprietary technologies and exclusive passenger terminal infrastructure have been positioned to support a transition from traditional helicopters and fixed-wing aircraft to Electric Vertical Aircraft (EVA or eVTOL), with the stated goal of enabling quieter and emission-free air mobility.

Transition from Blade Air Mobility to Strata Critical Medical

Based on an August 29, 2025 Form 8-K, Blade Air Mobility, Inc. changed its name to Strata Critical Medical, Inc. and its Nasdaq trading symbol changed from BLDE to SRTA. The same filing explains that the company completed the previously announced sale of its Passenger business to a subsidiary of Joby Aviation, Inc. The transaction included Blade’s passenger operations and related assets, while the remaining public company continues under the Strata Critical Medical name.

In related press releases, the company has indicated that following the closing of the passenger divestiture, the remaining business would focus on mission critical logistics and medical services to hospitals and healthcare providers throughout the country. The medical division, which includes the Trinity Medical Solutions business, has been described as one of the largest air transporters of human organs for transplant in the United States. The company has also highlighted a long-term commercial relationship under which Joby’s aircraft may be used for medical transport services, reflecting an ongoing connection between advanced air mobility technology and Strata’s medical logistics operations.

Business Focus Under the BLDE Ticker

While trading as BLDE, Blade Air Mobility’s activities, as described in its public communications, included:

  • Medical air logistics: Providing transportation and logistics for hospitals across the United States, with a focus on the movement of human organs for transplant and related time-critical medical services.
  • Passenger air mobility: Offering, selling, promoting, marketing, planning, booking, brokering, coordinating and arranging transportation of passengers on aircraft operated by third parties, including helicopter and fixed-wing services in key urban and regional corridors.
  • Terminal and lounge infrastructure: Operating exclusive passenger terminal and lounge infrastructure in major urban markets to support its passenger air mobility services.
  • Technology platform: Using proprietary technologies to manage bookings, logistics, and operations, and to prepare for integration of Electric Vertical Aircraft (EVA/eVTOL) into its model.

The company has repeatedly described its approach as asset-light, reflecting its reliance on third-party aircraft operators rather than owning and operating the aircraft fleet itself. Its communications also emphasize the role of EVA/eVTOL technology in enabling quieter and emission-free air mobility, and the company has participated in demonstration flights with electric aircraft manufacturers to advance this objective.

Corporate Actions and Strategic Transactions

SEC filings and press releases indicate several notable corporate developments associated with the BLDE ticker:

  • Sale of Passenger Business: An Equity Purchase Agreement dated August 1, 2025, and subsequent Form 8-K filings describe the agreement for a subsidiary of Joby Aviation to acquire Blade’s passenger business. A Form 8-K dated August 29, 2025 reports completion of this sale and notes that the consideration was paid in Joby Aviation common stock, with potential additional contingent consideration based on specified performance and retention metrics.
  • Name and Ticker Change: The August 29, 2025 Form 8-K explains that the company amended its certificate of incorporation to change its name from Blade Air Mobility, Inc. to Strata Critical Medical, Inc. and that its Nasdaq trading symbol changed to SRTA at the market open on August 29, 2025.
  • Post-transaction focus: Company press releases describe the post-transaction entity (Strata Critical Medical) as a pure-play contractual healthcare and medical logistics business, with an emphasis on mission critical logistics and medical services for hospitals and healthcare providers, and with a long-term commercial agreement giving Joby a role in providing certain medical transport services.

Industry Classification

For industry classification purposes, BLDE has been associated with All Other Business Support Services within the broader Administrative and Support and Waste Management and Remediation Services sector. Its actual operating activities, as described in its public disclosures, have centered on aviation logistics, medical transport, and passenger air mobility, supported by a technology-enabled platform and dedicated terminal infrastructure.

BLDE as a Historical Ticker

Because the company’s legal name and trading symbol have changed, BLDE serves as a historical ticker for investors researching the period when the company operated as Blade Air Mobility, Inc. and combined both passenger and medical air mobility businesses. Current information about the renamed entity and its ongoing operations is associated with the Strata Critical Medical, Inc. (SRTA) listing, as indicated in the company’s SEC filings.

Last Close
$4.73
EPS (FY2025)
$0.50
Revenue (FY2025)
$197.1M
Net Margin (FY2025)
21.0%
View full BLDE overview

Frequently Asked Questions

Blade Air Mobility, Inc. investment returns

How much was $1,000 invested in Blade Air Mobility, Inc. worth at its last close?

If you invested $1,000 in Blade Air Mobility, Inc. (BLDE) 5 years before its last close, on 2020-08-28, your investment was worth $473 on 2025-08-28, a -52.7% price return without dividends, growing at a compounded rate of -13.9% per year (CAGR).

Has Blade Air Mobility, Inc. outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare BLDE performance over available time periods.

What is Blade Air Mobility, Inc.'s average annual return?

The compound annual growth rate (CAGR) of BLDE’s share price over the 5 years to Aug 28, 2025 is -13.9%, without dividends. Individual years vary a great deal, and BLDE’s best recent full year was 2024 (+20.4%) while the worst was 2022 (-59.5%).

For informational and educational purposes only, not investment advice.